Forian Inc. (FORA)
$3.4
Rating:
Recommendation:
-
| Symbol | FORA |
|---|---|
| Price | $3.4 |
| Beta | 1.103 |
| Volume Avg. | 0.03M |
| Market Cap | 110.693M |
| Shares () | - |
| 52 Week Range | 2.0-7.19 |
| 1y Target Est | - |
| DCF Unlevered | FORA DCF -> | |
|---|---|---|
| DCF Levered | FORA LDCF -> | |
| ROE | -155.78% | Strong Sell |
| ROA | -63.33% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 235.62% | Strong Buy |
| P/E | -3.24 | Strong Sell |
| P/B | 7.61 | Strong Buy |
Latest FORA news
About
Download (Excel)Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.